AllenCHoMDFACS
Ophthalmology • Philadelphia, PARetinal Disease
Director of Retina Research Wills Eye Hospital Professor of Ophthalmology, Jefferson Medical College
Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
840 Walnut St
Fl 10
Philadelphia, PA 19107Phone+1 800-331-6634Fax+1 215-825-2443- Is this information wrong?
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 1989 - 1992
Atlantic Health System/Morristown Medical CenterInternship, Internal Medicine, 1988 - 1989
Columbia University Vagelos College of Physicians and SurgeonsClass of 1988
Certifications & Licensure
NJ State Medical License 1997 - 2025
PA State Medical License 1990 - 2024- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- 100 Most Influential Ophthalmologists in the World The Ophthalmologist, 2019-2023
- Top Docs of Philadelphia Philadelphia Magazine, 2008-2023
- Philadelphia Magazine Castle Connolly, 2008-2023
- Join now to see all
Clinical Trials
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion Start of enrollment: 2011 Sep 01
- New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System Start of enrollment: 2014 Jan 01
- Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment. Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 1 citationsGene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.Robert Avery, David M Brown, Jeffrey S Heier, Stephen Pakola, Charles C Wykoff, Sherri Van Everen, Peter A Campochiaro, Allen C Ho, Stephen M Huddleston, Glenn J Jaffe...> ;Lancet. 2024 Mar 27
- Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.Momenaei, B., Wakabayashi, T., Vemula, S., Durrani, A., Pandit, S., Hsu, J., Ho, A., Spirn, M., Klufas, M., Garg, S., Vander, J., Regillo, C., Chiang, A., Kuriyan, A.,...> ;The British Journal of Ophthalmology. 2024 Feb 12
- 1 citationsEnhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema.Nikhil K Mandava, Ajay E Kuriyan, Allen C Ho, Jason Hsu, Carl D Regillo, Michael A Klufas> ;Current Opinion in Ophthalmology. 2024 May 1
- Join now to see all
Press Mentions
Gene Therapy Can Restore Night Vision After Decades of Congenital BlindnessNovember 8th, 2022- Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness, Penn Study FindsOctober 10th, 2022
- REGENXBIO Announces RGX-314 Data Presentations at Retina Society 54th Annual Scientific Meeting and KOL Conference CallSeptember 27th, 2021
- Join now to see all
Professional Memberships
- Fellow
- Retina SocietyExecutive Board
- Macula SocietyMember
- Member
- Member
Hospital Affiliations
Jefferson Abington HealthAbington, Pennsylvania
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Wills Eye HospitalPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
